Building on our last topic of determining necessary competencies and roles needed by a biopharma company as it scales operations to commercialize a product, on March 21st we will discuss the implications of various resourcing theories that could assist you in making sound insourcing versus outsourcing decisions.
Whether you’re at an emerging company or reside within an established organization, understanding practical resourcing theories and how they apply to the acquisition of capabilities to meet your objectives are critical to your ongoing success in the future.
If you are curious about how program and launch leaders can play a strategic role in identifying organizational gaps to achieve their goals and to ensure disciplined thinking to the best resource for those goals, with both short- and long-term perspectives, join us for our workshop next Thursday, March 21st.
Our session leader for the ‘Insourcing vs. Outsourcing in Biopharma’ workshop will be Tyson Bertmaring, Director of Program Management at CRISPR Therapeutics.
Please confirm below that you'll be joining us for this session in Cambridge, MA on Thursday, March 21, 2019, from 5 – 7.30 pm.
We look forward to seeing you there, then!
Want to participate, yet can't make it to this session in Cambridge? Please let us know what time/place might work best for you.